Tools
Stock profile

ZIMMER BIOMET HOLDINGS, INC. (ZBH)

ZBH · Latest close $103.32 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$103.32
As of Nov 18, 2026
Tracked funds holding
7 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
6
vs previous quarter

ZIMMER BIOMET HOLDINGS, INC. (ZBH) is held by 7 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 6 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $824.0K sold). Latest close $103.32 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Sep 11, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-824.0K
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Hillman Capital Management · Sound Shore · Oakmark Funds — 7 tracked funds hold ZBH. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 2 sales ($824.0K). Insider trading

Often held alongside

CARRIER GLOBAL Corp (CARR) · BOEING CO (BA) · FISERV INC (FISV) · BP PLC (BP) · GILEAD SCIENCES, INC. (GILD) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Hillman Capital Management3.36%53,943TRIMMED (-3.2%) Q3 filed Nov 16
Sound Shore2.11%794,602TRIMMED (-24.5%) Q3 filed Nov 6
Oakmark Funds1.45%12,738,025TRIMMED (-1.7%) Q3 filed Nov 16
Dodge & Cox Funds1.09%24,124,735ADDED (+2.5%) Q3 filed Nov 13
Causeway Capital Management0.74%788,810TRIMMED (-2.4%) Q3 filed Nov 13
Mairs & Power Funds0.01%6,625TRIMMED (-17.7%) Q3 filed Nov 16
Ariel Investments<0.01%2,999TRIMMED (-0.5%) Q3 filed Nov 13

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +21.3% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

113.1878.242024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding902 of 8,857 filers
Long-only filers among them900
Change vs 2026 Q1+6 net · 829 entered · 823 exited
Shares reported, all filers197,964,781
Reported value, all filers$16.3B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Revenue · FY2025$8.2B
Net income · FY2025$705.1M
Total assets · FY2025$23.1B
Shares outstanding190,737,689
Market cap (at latest close)$19.7B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 30, 2026.

Short interest

Shares short · Oct 15, 20267,959,713
Share of shares outstanding4.17%
Days to cover3.94

Shares short at recent settlements — Jul 31, 2026: 11.2M · Aug 14, 2026: 8.8M · Aug 31, 2026: 8.8M · Sep 15, 2026: 8.6M · Sep 30, 2026: 9.7M · Oct 15, 2026: 8.0M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 30, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 4K · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 30, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 2 sales by 2 insiders ($824.0K).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Sep 11, 2026Thornal Kevin RGrp Pres-Global BusinessSell5,691$92.95$529.0KSEC filing
Sep 4, 2026Phipps Chad FSee remarks below.Sell3,000$98.35$295.1KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Sep 11, 2026Thornal Kevin ROfficer5,691$529.0KSep 11, 2026SEC filing
Sep 4, 2026Phipps Chad FOfficer3,000$295.1KSep 4, 2026SEC filing
Jul 16, 2026Upadhyay SuketuFormer Officer7,668$712.1KJul 16, 2026SEC filing
Jun 24, 2026Upadhyay SuketuFormer Officer4,560$410.7KJun 24, 2026SEC filing
May 29, 2026Yi SangOfficer5,000$413.2KMay 29, 2026SEC filing
May 19, 2026Upadhyay SuketuFormer Officer5,373$464.1KMay 19, 2026SEC filing
May 12, 2026Upadhyay SuketuFormer Officer31,253$2.6MMay 12, 2026SEC filing
Mar 12, 2026Winkler LoriOfficer2,650$250.8KMar 12, 2026SEC filing
Feb 12, 2026Yi SangOfficer1,000$96.5KFeb 12, 2026SEC filing
Sep 11, 2025Yi SangOfficer1,200$124.3KSep 11, 2025SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 13, 2026Dodge & CoxSC 13G/A24,124,73512.5%Jun 30, 2026SEC filing
Aug 12, 2026Capital International InvestorsSC 13G12,438,3666.4%Jun 30, 2026SEC filing
May 15, 2026T. Rowe Price Associates, Inc.SC 13G/A7,997,8064.1%Mar 31, 2026SEC filing
Apr 30, 2026Vanguard Capital ManagementSC 13G14,767,5277.5%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 17, 2026HARRIS ASSOCIATES L PSC 13G12,264,7036.2%Dec 31, 2025SEC filing
Aug 13, 2025Dodge & CoxSC 13G/A22,097,46311.2%Jun 30, 2025SEC filing
May 6, 2025Dodge & CoxSC 13G/A20,087,11810.2%Apr 30, 2025SEC filing
Apr 17, 2025BlackRock, Inc.SC 13G/A15,573,1877.8%Mar 31, 2025SEC filing
Feb 13, 2025Dodge & CoxSC 13G/A19,118,4369.6%Dec 31, 2024SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 168 Lobbying Disclosure Act filings named this company as client, 2005–2026; most common issues: Health Issues (135), Taxation/Internal Revenue Code (114), Medicare/Medicaid (80).

Federal contracts: $126.6M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$33.1M
FY2022$25.8M
FY2023$16.7M
FY2024$17.4M
FY2025$22.9M
FY2026$10.6M

Largest awards collected

Award IDAgencyAmountStart
36C26020P0655Department of Veterans Affairs$1.4MAug 28, 2020
75H71021P01212Department of Health and Human Services$1.1MApr 16, 2021
36C25623P1502Department of Veterans Affairs$999.2KAug 25, 2023
36C24723P0308Department of Veterans Affairs$918.5KApr 30, 2023
SPE2D622F6CU4Department of Defense$903.0KSep 12, 2022

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

· Graham — Sound finances and a long run of profits

· Dividend Growth — Dividends raised for more than 10 years

· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Shareholder Yield — Cash returned through dividends and buybacks

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Growth — Latest revenue: $8.2B · 5-yr revenue CAGR: 6.1% · Straight growth years: 5

· Graham — Current ratio: 1.98 · Straight profitable years: 5 · Debt ratio: 0.82 · Latest net income: $705.1M

· Dividend Growth — Dividend per share: 0.96 · Dividend yield: 1.0% · Straight dividend years: 15 · 10-yr dividend growth: 0.0%

· Cash Flow (FCF) — Latest FCF: $1.5B · FCF yield: 7.6% · Positive FCF years: 3

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.87 · Operating cash flow: $1.7B · Net income: $705.1M

· Shareholder Yield — Shareholder yield: 3.5% · of which dividends: 1.0% · of which buybacks: 2.5%

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2023 Q3, ranked #4 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together1145.5%+1.8%+2.6%-0.9%
Share count tripled (3x)1100.0%+0.9%-8.2%+9.1%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold ZBH — ranked by lift, the co-holding pattern described in Methodology: CARRIER GLOBAL Corp (CARR) · BOEING CO (BA) · FISERV INC (FISV) · BP PLC (BP) · GILEAD SCIENCES, INC. (GILD) · VANGUARD FTSE EMERGING MARKE (VWO) · VANGUARD FTSE DEVELOPED ETF (VEA) · DIAGEO PLC (DEO).

Recent 8-K filings

FiledItemsSource
Nov 12, 20261.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 9.01 Financial Statements and ExhibitsSEC filing
Nov 4, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Sep 8, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

CARRIER GLOBAL Corp (CARR) · Track Record: how the signals scored · Practice timing on ZBH

One email a week: the week’s new filings and research. Subscribe free

← Z  ·  ZBRA →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.